Prostaglandin Metabolites Analysis in Urine by LC-MS/MS

Guille Metzler,Lily A Day,Richard C King,Carmen Fernández-Metzler,Amitava Das,T Gregg Davis,Besnik Bajrami,Tom Bretschneider,David Kvaskoff
DOI: https://doi.org/10.1007/978-1-0716-4116-3_9
Abstract:The analysis of prostaglandin urinary metabolites is valuable for assessing physiological processes and identifying disease biomarkers. These metabolites, derived from the breakdown of prostaglandins, offer a noninvasive means to gauge prostaglandin production and its potential impact on various biological functions. We report an efficient LC-MS method of four commonly analyzed prostaglandin urinary metabolites including tetranor-PGEM (derived from PGE2), tetranor-PGDM, 11β-PGF2α, and 2,3-dinor-11β-PGF2α (derived from PGD2). Each metabolite possesses distinct characteristics and clinical applications, collectively contributing to our understanding of prostaglandin-mediated pathways.
What problem does this paper attempt to address?